499 related articles for article (PubMed ID: 7199538)
1. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
2. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
Sakata Y; Aoki N
J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
[TBL] [Abstract][Full Text] [Related]
4. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
Aoki N; Sakata Y; Ichinose A
Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
[TBL] [Abstract][Full Text] [Related]
5. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
Mimuro J; Kimura S; Aoki N
J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor.
Kimura S; Tamaki T; Aoki N
Blood; 1985 Jul; 66(1):157-60. PubMed ID: 3159442
[TBL] [Abstract][Full Text] [Related]
7. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
Koncz Z; Bagoly Z; Haramura G; Mezei ZA; Muszbek L
Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462
[TBL] [Abstract][Full Text] [Related]
8. Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor.
Sakata Y; Eguchi Y; Mimuro J; Matsuda M; Sumi Y
Blood; 1989 Dec; 74(8):2692-7. PubMed ID: 2510836
[TBL] [Abstract][Full Text] [Related]
9. Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin.
Aoki N
Thromb Haemost; 1993 Aug; 70(2):376. PubMed ID: 8236154
[No Abstract] [Full Text] [Related]
10. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency.
Sakata Y; Mimuro J; Aoki N
Blood; 1984 Jun; 63(6):1393-401. PubMed ID: 6232970
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
Sakai M; Watanuki M; Matsuo O
Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
[TBL] [Abstract][Full Text] [Related]
12. The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin.
Ichinose A; Aoki N
Thromb Res; 1986 Mar; 41(6):847-54. PubMed ID: 2939589
[TBL] [Abstract][Full Text] [Related]
13. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.
Hethershaw EL; Cilia La Corte AL; Duval C; Ali M; Grant PJ; Ariëns RA; Philippou H
J Thromb Haemost; 2014 Feb; 12(2):197-205. PubMed ID: 24261582
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
15. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
16. Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link.
Takada A; Watahiki Y; Takada Y
Thromb Res; 1986 Mar; 41(5):605-13. PubMed ID: 3083529
[TBL] [Abstract][Full Text] [Related]
17. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
Ries M; Klinge J; Rauch R; Keuper H; Harms D
Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
[TBL] [Abstract][Full Text] [Related]
18. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
Schneider M; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
[TBL] [Abstract][Full Text] [Related]
19. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
Robbie LA; Booth NA; Croll AM; Bennett B
Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
[TBL] [Abstract][Full Text] [Related]
20. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
Takada A; Shizume K; Cho M; Takada Y
Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
